Evidence map›Paper›PMID 40604258›Full record

ArticleScientific reports2025

Evaluation of alginate-based coatings enriched with postbiotics from Bifidobacterium spp. on the quality and safety of Turkey meat.

Emel Cengiz Kaynakci

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Emel Cengiz KaynakciInstitute of Health Sciences, Department of Medical Biotechnology, Akdeniz University, 07070, Antalya, Konyaaltı, Turkey. ekaynakci@akdeniz.edu.tr.ORCID http://orcid.org/0000-0002-2152-0262

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study evaluated the antimicrobial and antioxidant properties of postbiotics derived from Bifidobacterium bifidum DSM 20,456 (b1), Bifidobacterium bifidum BB12 (b2), and their combination (bb) in alginate-based edible coatings for fresh turkey breast meat. Coated and uncoated samples were stored at 4 °C for seven days, with microbial and physicochemical analyses conducted at regular intervals (0, 2, 4, 7 days). The postbiotic-enriched coatings exhibited significant antioxidant activity, with total phenolic content (TPC) ranging from 87.13 to 90.89 mg GAE/100 mL and DPPH radical scavenging capacity between 50.28 and 51.56 mg TEAC/100 mL (p < 0.05). While TBARS values were lower in postbiotic-treated groups, the differences were not statistically significant (p > 0.05). Water holding capacity (WHC) was maintained at higher levels in postbiotic-treated samples throughout storage. Microbial analysis revealed that total aerobic mesophilic and psychrotrophic bacterial counts were not significantly affected (p > 0.05), whereas Listeria monocytogenes counts were significantly reduced in coated samples (p < 0.05), with the bb formulation achieving a 1.62 log₁₀ CFU/g reduction. Fourier Transform Infrared (FTIR) spectroscopy confirmed molecular interactions between postbiotics and the alginate matrix, enhancing coating stability. These findings suggest that postbiotic-alginate coatings effectively inhibit L. monocytogenes while maintaining the physicochemical stability of turkey meat, highlighting their potential in poultry preservation. However, further optimization, such as combining postbiotics with additional antimicrobial agents, is needed to enhance overall microbial control.

Indexed as

AlginatesBifidobacteriumMeatProbioticsAnimalsAntioxidantsFood MicrobiologyFood PreservationGlucuronic AcidHexuronic AcidsListeria monocytogenesTurkeysAlginatesAntioxidantsGlucuronic AcidHexuronic AcidsAlginateBifidobacterium bifidum BB12Bifidobacterium bifidum DSM 20456Edible coatingPostbioticsShelf lifeTurkey meat

Identifiers

PMID40604258
PMCPMC12223296

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.